The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer
Abstract
Aiming at improved therapeutic efficacies, the combination of chemotherapy and radiotherapy (chemo-radiotherapy) has been widely studied and applied in clinic. However, the hostile characteristics of tumor microenvironment such as hypoxia often limit the efficacies in both types of cancer therapies. Herein, catalase (CAT), an antioxidant enzyme, is encapsulated inside liposomes constituted by cisplatin (IV)-prodrug-conjugated phospholipid, forming CAT@Pt (IV)-liposome for enhanced chemo-radiotherapy of cancer. After being loaded inside liposomes, CAT within CAT@Pt (IV)-liposome shows retained and well-protected enzyme activity, and is able to trigger decomposition of H 2 O 2 produced by tumor cells, so as to produce additional oxygen for hypoxia relief. As the result, treatment of CAT@Pt (IV)-liposome induces the highest level of DNA damage in cancer cells after X-ray radiation compared to the control groups. In vivo tumor treatment further demonstrates a remarkably improved therapeutic outcome in chemo-radiotherapy with such CAT@Pt (IV)-liposome nanoparticles. Hence, an exquisite type of liposome-based nanoparticles is developed in this work by integrating cisplatin-based chemotherapy and catalase-induced tumor hypoxia relief together for combined chemo-radiotherapy with great synergistic efficacy, promising for clinical translation in cancer treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, in situ generation of oxygen using catalase as an enzyme is attractive because it is self-responsive to hydrogen peroxide (H2O2) and does not require pre-treatment with oxygen ( 3 O2).18,19,24”
From Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor (2019) · cites this paper as [19]
Citations
Cites
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Macdonald, J. S., Smalley, S. R., Benedetti, J., Hundahl, S. A., Estes, N. C., Stemmermann, G. N., Haller, D. G., Ajani, J. A., Gunderson, L. L., Jessup, J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010187 · Cited by 3,470
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
Forastiere, A. A., Goepfert, H., Maor, M. H., Pajak, T. F., Weber, R. S., Morrison, W. H., Glisson, B. S., Trotti, A., Ridge, J. A., Chao, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031317 · Cited by 3,161
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
The Department of Veterans Affairs Laryngeal Cancer Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242402 · Cited by 2,755
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J., Hickey, H., Beger, H. G., Fernández‐Cruz, L., Dervenis, C., LACAINE, F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032295 · Cited by 2,709
D'Amico, A., Whittington, R., Malkowicz, S., Schultz, D., Blank, K., Broderick, G., Tomaszewski, J., Renshaw, A., Kaplan, I., Beard, C., et al. (1998) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.280.11.969 · Cited by 2,697
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., Clarke‐Pearson, D. L., & Insalaco, S. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401502 · Cited by 2,662
A simple method for determination of serum catalase activity and revision of reference range
Góth, L. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90067-m · Cited by 2,391
Al‐Sarraf, M., LeBlanc, M. L., Giri, P. G., Fu, K. K., Cooper, J. S., Vuong, T., Forastiere, A. A., Adams, G. L., Sakr, W., Schuller, D. E., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1310 · Cited by 2,218
Cited by
Sorted by citations
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 458
Emerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization
Xie, J., Gong, L., Zhu, S., Yong, Y., Gu, Z., & Zhao, Y. (2018) · Advanced Materials · doi:10.1002/adma.201802244 · Cited by 418
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X. S., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 413
Self-citationX-ray-activated nanosystems for theranostic applications
Chen, X., Song, J., Chen, X. S., & Yang, H. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00921j · Cited by 403
Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor
Phua, S. Z. F., Yang, G., Lim, W. Q., Verma, A., Chen, H., Thanabalu, T., & Zhao, Y. (2019) · ACS Nano · doi:10.1021/acsnano.9b01087 · Cited by 375
Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics
Gong, F., Yang, N., Wang, X., Zhao, Q., Chen, Q., Liu, Z., & Cheng, L. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100851 · Cited by 366
Self-citationNanomedicine for tumor microenvironment modulation and cancer treatment enhancement
Liu, J., Chen, Q., Feng, L., & Liu, Z. (2018) · Nano Today · doi:10.1016/j.nantod.2018.06.008 · Cited by 328
Self-citationBai, J., Jia, X., Zhen, W., Cheng, W., & Jiang, X. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11114 · Cited by 272
Fan, J., Deng, R., Wang, H., Liu, X., Wang, X., Qin, R., Jin, X., Lei, T.-R., Zheng, D., Zhou, P., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03245 · Cited by 268
Carbon‐Based Nanomaterials for Cancer Therapy via Targeting Tumor Microenvironment
Saleem, J., Wang, L., & Chen, C. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800525 · Cited by 263
Ke, W., Li, J., Mohammed, F., Wang, Y., Tou, K., Liu, X., Wen, P., Kinoh, H., Anraku, Y., Chen, H., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b09082 · Cited by 254
Deng, Y., Jia, F., Chen, S., Shen, Z., Jin, Q., Fu, G., & Ji, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.043 · Cited by 247
Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy
Zhang, R., Feng, L., Dong, Z., Wang, L., Liang, C., Chen, J., Ma, Q., Zhang, R., Chen, Q., Wang, Y., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.004 · Cited by 235
Self-citationExploring Therapeutic Potential of Catalase: Strategies in Disease Prevention and Management
Anwar, S., Alrumaihi, F., Sarwar, T., Babiker, A. Y., Khan, A. A., Prabhu, S. V., & Rahmani, A. H. (2024) · Biomolecules · doi:10.3390/biom14060697 · Cited by 278
Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia
Sahu, A., Kwon, I., & Tae, G. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119578 · Cited by 219
Wang, J., Sun, J., Hu, W., Wang, Y., Chou, T., Zhang, B., Zhang, Q., Ren, L., & Wang, H. (2020) · Advanced Materials · doi:10.1002/adma.202001862 · Cited by 223
Sun, H., Xu, J., Wang, Y., Shen, S., Xu, X., Zhang, L., & Jiang, Q. Y. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.12.021 · Cited by 215
Tao, D., Feng, L., Chao, Y., Liang, C., Song, X., Wang, H., Yang, K., & Liu, Z. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201804901 · Cited by 207
Self-citationZhang, R., Chen, L., Liang, Q. Y., Xi, J., Zhao, H., Jin, Y., Gao, X., Yan, X., Gao, L., & Fan, K. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101317 · Cited by 203
Self-citationRecent advances of redox-responsive nanoplatforms for tumor theranostics
Chen, M., Liu, D., Liu, F., Wu, Y., Peng, X., & Song, F. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.030 · Cited by 192
Shi, C. J., Li, M., Zhang, Z., Yao, Q., Shao, K., Xu, F., Xu, N., Li, H., Fan, J., Sun, W. C., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119755 · Cited by 192
Yang, Y., Chen, M., Wang, B., Wang, P., Liu, Y., Zhao, Y., Li, K., Song, G., Zhang, X., & Tan, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201906758 · Cited by 183
Self-citationBreaking the Depth Dependence by Nanotechnology‐Enhanced X‐Ray‐Excited Deep Cancer Theranostics
Fan, W., Tang, W., Lau, J., Shen, Z., Xie, J., Shi, J., & Chen, X. S. (2019) · Advanced Materials · doi:10.1002/adma.201806381 · Cited by 181
Antioxidative nanomaterials and biomedical applications
Liu, Y., & Shi, J. (2019) · Nano Today · doi:10.1016/j.nantod.2019.05.008 · Cited by 174
Recent advances in porphyrin-based MOFs for cancer therapy and diagnosis therapy
Wang, Z., Sun, Q., Liu, B., Kuang, Y., Gulzar, A., He, F., Gai, S., Yang, P., & Lin, J. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.213945 · Cited by 170
Feng, L., Dong, Z., Liang, C., Chen, M., Tao, D., Cheng, L., Yang, K., & Liu, Z. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.049 · Cited by 166
Self-citationEncapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?
Klojdová, I., Milota, T., Smetanová, J., & Stathopoulos, C. E. (2023) · Pharmaceuticals · doi:10.3390/ph16030362 · Cited by 166
Xia, D., Xu, P., Luo, X., Zhu, J., Gu, H., Huo, D., & Hu, Y. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807294 · Cited by 150
Zhang, M., Liu, X., Luo, Q., Wang, Q., Zhao, L., Deng, G., Ge, R., Zhang, L., Hu, J., & Lü, J. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.124450 · Cited by 147
Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy
Zhang, C., Yan, L., Gu, Z., & Zhao, Y. (2019) · Chemical Science · doi:10.1039/c9sc02107h · Cited by 146
Farooq, M. A., Aquib, M., Farooq, A., Khan, D. H., Maviah, M. B. J., Filli, M. S., Kesse, S., Boakye‐Yiadom, K. O., Mavlyanova, R., Parveen, A., et al. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1604535 · Cited by 133
Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy
Wang, H., Li, J., Wang, Y., Gong, X., Xu, X., Wang, J., Li, Y., Sha, X., & Zhang, Z. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.028 · Cited by 129
Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview
Lungu, I. I., Grumezescu, A. M., Volceanov, A., & Andronescu, E. (2019) · Molecules · doi:10.3390/molecules24193547 · Cited by 121
Liu, G., Zhang, S., Shi, Y., Huang, X., Tang, Y., Chen, P., Si, W., Huang, W., & Dong, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201804317 · Cited by 115
Wang, Y., Wu, W., Mao, D., Teh, C., Wang, B., & Liu, B. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202002431 · Cited by 114
Liu, J., Wang, L., Shen, X., Gao, X., Chen, Y., Liu, H., Liu, Y., Yin, D., Liu, Y., Xu, W., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100907 · Cited by 105
Selenium-Containing Nanomaterials for Cancer Treatment
Li, T., & Xu, H. (2020) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2020.100111 · Cited by 105
Zhang, Y., Xi, K., Fu, X., Sun, H., Wang, H., Yu, D., Li, Z., Ma, Y., Liu, X., Huang, B., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121163 · Cited by 104
Jin, J., & Zhao, Q. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00629-y · Cited by 103
Cheng, X., He, L., Xu, J., Fang, Q., Lü, Y., Xue, Y., Wang, X., & Tang, R. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.05.035 · Cited by 96
Ma, Y., Zhu, Y., Tang, X., Hang, L., Jiang, W., Li, M., Khan, M. I., You, Y., & Wang, Y. (2019) · Biomaterials Science · doi:10.1039/c9bm00333a · Cited by 97
Hua, Y., Huang, J., Shao, Z., Luo, X., Wang, Z., Liu, J., Zhao, X., Chen, X. S., & Zang, S. (2022) · Advanced Materials · doi:10.1002/adma.202203734 · Cited by 97
de la Torre, P., Pérez-Lorenzo, M. J., Alcazar-Garrido, A., & Flores, A. I. (2020) · Molecules · doi:10.3390/molecules25030715 · Cited by 96
Delivering metal ions by nanomaterials: Turning metal ions into drug-like cancer theranostic agents
Liu, C., Guo, L., Wang, Y., Zhang, J., & Fu, C. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215332 · Cited by 90
Dan, Q., Hu, D., Ge, Y., Zhang, S., Li, S., Gao, D., Luo, W., Ma, T., Liu, X., Zheng, H., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm01742a · Cited by 90
Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer
Li, S., Hao, Y., Wang, C., Han, Y., Zhu, Y., Feng, L., Miao, L., & Liu, Z. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.013 · Cited by 88
Self-citationMa, S., Zhou, J., Zhang, Y., Yang, B., He, Y., Tian, C., Xu, X., & Gu, Z. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b19840 · Cited by 87
Protein-Based Nanomedicine for Therapeutic Benefits of Cancer
Zhang, Q., Zhang, J., Song, J., Liu, Y., Ren, X., & Zhao, Y. (2021) · ACS Nano · doi:10.1021/acsnano.1c00476 · Cited by 84
Wen, M., Yu, N., Wu, S., Huang, M., Qiu, P., Ren, Q., Zhu, M., & Chen, Z. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.03.009 · Cited by 81
Jin, X., Shan, J., Zhao, J., Wang, T., Zhang, W., Yang, S., Qian, H., Cheng, L., Chen, X., & Wang, X. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.10.028 · Cited by 80
Yin, W., Ming, Q., Ke, W., Han, Y., Mukerabigwi, J. F., & Ge, Z. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.014 · Cited by 80
Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics
Park, H., Saravanakumar, G., Kim, J., Lim, J., & Kim, W. J. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000834 · Cited by 82
He, C., Zhang, X., Yan, R., Zhao, P., Chen, Y., Li, M., Chen, C., Fan, T., Lu, Y., Wang, C., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm00797k · Cited by 75
Mohammadi, A., Jafari, S. M., Mahoonak, A. S., & Ghorbani, M. (2020) · Food and Bioprocess Technology · doi:10.1007/s11947-020-02513-x · Cited by 75
Zhang, Y., Xu, Y., Sun, D., Meng, Z., Ying, W., Gao, W., Hou, R., Zheng, Y., Cai, X., Hu, B. Q., et al. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.124521 · Cited by 75
Biointerface engineering nanoplatforms for cancer-targeted drug delivery
Zhang, H., Dong, S., Li, Z., Feng, X., Xu, W., Tulinao, C. M. S., Jiang, Y., & Ding, J. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.11.004 · Cited by 73
Synthetic cells in biomedical applications
Sato, W., Zajkowski, T., Moser, F., & Adamala, K. P. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1761 · Cited by 77
Gas Therapy: An Emerging “Green” Strategy for Anticancer Therapeutics
Jin, Q., Deng, Y., Jia, F., Tang, Z., & Ji, J. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800084 · Cited by 71
Huang, W., Zhang, L., Sun, J., Sun, Y., Gong, L., Ge, S., Zheng, Y., Gao, W., & Wei, X. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c13501 · Cited by 72
Advanced nanotechnology for hypoxia-associated antitumor therapy
Zhao, L., Fu, C., Tan, L., Li, T., Zhong, H., & Meng, X. (2020) · Nanoscale · doi:10.1039/c9nr09071a · Cited by 69
Zhou, R., Ohulchanskyy, T. Y., Xu, H., Ziniuk, R., & Qu, J. (2021) · Small · doi:10.1002/smll.202103569 · Cited by 68
Yao, H., Guo, X., Zhou, H., Ren, J., Li, Y., Duan, S., Gong, X., & Du, B. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c03022 · Cited by 68
Protein‐Based Artificial Nanosystems in Cancer Therapy
Zhang, N., Mei, K., Guan, P., Hu, X., & Zhao, Y. (2020) · Small · doi:10.1002/smll.201907256 · Cited by 68
Therapeutic Nanoreactors as In Vivo Nanoplatforms for Cancer Therapy
Mukerabigwi, J. F., Ge, Z., & Kataoka, K. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201801159 · Cited by 65
Hei, Y., Teng, B., Zeng, Z., Zhang, S., Li, Q., Pan, J., Luo, Z., Xiong, C., & Wei, S. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s225807 · Cited by 65
Catalytic nanographene oxide with hemin for enhanced photodynamic therapy
Sahu, A., Min, K., Jeon, J., Yang, H. S., & Tae, G. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.023 · Cited by 64
Huang, Y., Canup, B. S. B., Gou, S., Chen, N., Dai, F., Xiao, B., & Li, C. M. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02092c · Cited by 63
Mosleh-Shirazi, S., Abbasi, M., Shafiee, M., Kasaee, S. R., & Amani, A. M. (2021) · Materials Today Communications · doi:10.1016/j.mtcomm.2021.102064 · Cited by 66
Su, S., Chen, Y., Zhang, P., Ma, R., Zhang, W., Liu, J., Li, T., Niu, H., Cao, Y., Hu, B., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114680 · Cited by 63
Su, M., Zhu, Y., Chen, J., Zhang, B., Sun, C., Chen, M., & Yang, X. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134926 · Cited by 61
Preparation of therapeutic-laden konjac hydrogel for tumor combination therapy
Liu, Y., Xi, Y., Zhao, J., Zhao, J., Li, J., Huang, G., Li, J., Fang, F. Y., Gu, L., & Wang, S. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.122048 · Cited by 61
Nanomaterials for radiotherapeutics-based multimodal synergistic cancer therapy
Yang, X., Gao, L., Guo, Q., Li, Y., Ma, Y., Yang, J., Gong, C., & Cheng, Y. (2020) · Nano Research · doi:10.1007/s12274-020-2722-z · Cited by 58
Advanced nanomaterials targeting hypoxia to enhance radiotherapy
Li, J., Shang, W., Li, Y., Fu, S., Tian, J., & Lu, L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s173914 · Cited by 57
Fabrication of H 2 O 2 -driven nanoreactors for innovative cancer treatments
Dong, Z., Yang, Z., Hao, Y., & Feng, L. (2019) · Nanoscale · doi:10.1039/c9nr04418c · Cited by 56
Self-citationZhao, H., Wang, J., Li, X., Li, Y., Li, C., Wang, X., Wang, J., Guan, S., Xu, Y., Deng, G., et al. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.06.174 · Cited by 56
Jing, X., Zhi, Z., Zhang, N., Song, H., Xu, Y., Zhou, G., Wang, D., Shao, Y., & Meng, L. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.123893 · Cited by 55
Pei, Y., Li, M., Hou, Y., Hu, Y., Chu, G., Dai, L., Li, K., Xing, Y., Tao, B., Yu, Y., et al. (2018) · Nanoscale · doi:10.1039/c8nr02358a · Cited by 54
An Oxygen Self‐Evolving, Multistage Delivery System for Deeply Located Hypoxic Tumor Treatment
Jiang, W., Han, X., Zhang, T., Xie, D., Zhang, H., & Hu, Y. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901303 · Cited by 54
Li, T., Pan, S., Zhuang, H., Gao, S., & Xu, H. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b01172 · Cited by 54
Nanomaterials for Tumor Hypoxia Relief to Improve the Efficacy of ROS-Generated Cancer Therapy
Ruan, C., Su, K., Zhao, D., Lu, A., & Zhong, C. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.649158 · Cited by 52
The past, present, and future of enzyme-based therapies
Hennigan, J. N., & Lynch, M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.004 · Cited by 52
High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
Seo, H., Jeon, L., Kwon, J., & Lee, H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203033 · Cited by 54
Wang, C., Sun, X., Feng, L., & Liu, Z. (2024) · BMEMat · doi:10.1002/bmm2.12083 · Cited by 52
Self-citationA Tumor Vascular‐Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia
Luan, X., Guan, Y., Liu, H., Lu, Q., Zhao, M., Sun, D., Lovell, J. F., Sun, P., Chen, H., & Fang, C. (2018) · Advanced Science · doi:10.1002/advs.201800034 · Cited by 50
Musielak, M., Potoczny, J., Boś, A., & Kozak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126229 · Cited by 50
Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
Gilabert‐Oriol, R., Ryan, G. M., Leung, A. W. Y., Firmino, N. S., Bennewith, K. L., & Bally, M. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102922 · Cited by 53
Advances of Nanomedicine in Radiotherapy
Liu, W., Chen, B., Zheng, H., Xing, Y., Chen, G., Zhou, P., Qian, L., & Min, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111757 · Cited by 51
Li, X., Wu, Y., Zhang, R., Bai, W., Ye, T., & Wang, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.683519 · Cited by 49
Self-citationHou, D., Zhang, N., Wang, M., Xu, S., Wang, Z., Hu, X., Lv, G., Wang, J., Wu, X., Wang, L., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202116893 · Cited by 48
Pre- and post-irradiation mild hyperthermia enabled by NIR-II for sensitizing radiotherapy
Li, Q., Hang, L., Jiang, W., Dou, J., Xiao, L., Tang, X., Yao, Y., & Wang, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120235 · Cited by 48
Najafi, A., Keykhaee, M., Khorramdelazad, H., Karimi, M. Y., Samimi, L. N., Aghamohamadi, N., Karimi, M., Falak, R., & Khoobi, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113483 · Cited by 48
Dong, Z., Liu, Y., Wang, C., Hao, Y., Fan, Q., Yang, Z., Li, Q., Feng, L., & Liu, Z. (2023) · Advanced Materials · doi:10.1002/adma.202308254 · Cited by 47
Self-citationSelf-assembly regulated anticancer activity of platinum coordinated selenomethionine
Li, T., Xiang, W., Li, F., & Xu, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.12.001 · Cited by 47
Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
Li, Y.-N., Xu, P., He, D., Xu, B., Tu, J., & Shen, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s250773 · Cited by 46
Bioenzyme-based nanomedicines for enhanced cancer therapy
Ding, M., Zhang, Y., Li, J., & Pu, K. (2022) · Nano Convergence · doi:10.1186/s40580-022-00297-8 · Cited by 47
Harnessing Tumor Microenvironment for Nanoparticle‐Mediated Radiotherapy
Zhu, S., Gu, Z., & Zhao, Y. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800050 · Cited by 44
Xu, P., Wang, X., Li, T., Wu, H., Li, L., Chen, Z., Zhang, L., Guo, Z. G., & Chen, Q. (2020) · Nanoscale · doi:10.1039/c9nr08930f · Cited by 44
Calori, I. R., Bi, H., & Tedesco, A. C. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00945 · Cited by 45
A Robust Oxygen Microbubble Radiosensitizer for Iodine‐125 Brachytherapy
Peng, S., Song, R., Lin, Q., Zhang, Y., Yang, Y., Luo, M., Zhong, Z., Xu, X., Lu, L., Yao, S., et al. (2021) · Advanced Science · doi:10.1002/advs.202002567 · Cited by 44
Self-citation
Metadata
- Authors
- Zhang, R., Song, X., Liang, C., Yi, X., Song, G., Chao, Y., Yang, Y., Yang, K., Feng, L., & Liu, Z.
- Affiliations
- Soochow University (CN)
- Corresponding author
- Feng, Liangzhu
- Liu, Zhuang
- ORCID
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 138
- Pages
- 13-21
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2616024862
- Cited by
- 255
- References
- 45
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 21 · 2023: 31 · 2022: 41 · 2021: 34 · 2020: 39 · 2019: 34 · 2018: 25 · 2017: 6
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology (MOST) of China (2016YFA0201200)
- National Natural Science Fundation of China (51525203)
- Collaborative Innovation Center of Suzhou Nano Science and Technology
- Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- catalase, cisplatin prodrug, liposomes, tumor hypoxia, chemoradiotherapy, radiotherapy, hydrogen peroxide decomposition, DNA damage, tumor microenvironment, cancer therapy
- MeSH terms
- Tumor Hypoxia, Animals, Antineoplastic Agents, Antioxidants, Catalase, Cisplatin, DNA Damage, Female, Hydrogen Peroxide, Liposomes, Mice, Inbred BALB C, Neoplasms, Neoplasms, Experimental, Phospholipids, Prodrugs, Cell Line, Tumor, Mice, Nanoparticles, Chemoradiotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
